Proteomics of membrane receptors and signaling

Proteomics

Volumn 8, Issue 19, 2008, Pages 4146-4155

  Kabbani, Nadine ^a  

^a INSTITUT JACQUES MONOD   (France)

Author keywords

Ligand gated ion channel; Module; Protein complex; Receptor; Signalplex

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCINE; MEMBRANE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; OPIATE RECEPTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; SEROTONIN;

FUNCTIONAL PROTEOMICS; GENETIC ASSOCIATION; ISOTOPE LABELING; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVIEW;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEOMICS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 55749115062     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800139     Document Type: Review

References (93)

1. Gentzel, M., Kocher, T., Wilm, M., Proteomics in biological research: The challenge to make proteins speak. Ernst Schering Res. Found. Workshop 2002, 38, 167-189.
2. Schwikowski, B., Uetz, P., Fields, S., A network of protein-protein interactions in yeast. Nat. Biotechnol. 2000, 18, 1257-1261.
3. Milligan, G., White, J. H., Protein-protein interactions at G-protein-coupled receptors. Trends Pharmacol. Sci. 2001, 22, 513-518.
4. Grant, S. G., O'Dell, T. J., Multiprotein complex signaling and the plasticity problem. Curr. Opin. Neurobiol. 2001, 11, 363-368.
5. Kabbani, N., Levenson, R., A proteomic approach to receptor signaling: Molecular mechanisms and therapeutic implications derived from discovery of the dopamine D2 receptor signalplex. Eur. J. Pharmacol. 2007, 572, 83-93.
6. Macher, B. A., Yen, T. Y., Proteins at membrane surfaces-a review of approaches. Mol. Biosyst. 2007, 3, 705-713.
7. Pluder, F., Morl, K., Beck-Sickinger, A. G., Proteome analysis to study signal transduction of G protein-coupled receptors. Pharmacol. Ther. 2006, 112, 1-11.
8. Leonoudakis, D., Conti, L. R., Radeke, C. M., McGuire, L. M., Vandenberg, C. A., A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels. J. Biol. Chem. 2004, 279, 19051-19063.
9. Stasyk, T., Schiefermeier, N., Skvortsov, S., Zwierzina, H. et al., Identification of endosomal epidermal growth factor receptor signaling targets by functional organelle proteomics. Mol. Cell. Proteomics 2007, 6, 908-922.
10. Kabbani, N., Woll, M. P., Levenson, R., Lindstrom, J. M., Changeux, J. P., Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics. Proc. Natl. Acad. Sci. USA 2007, 104, 20570-20575.
11. Bray, D., Signaling complexes: Biophysical constraints on intracellular communication. Annu. Rev. Biophys. Biomol. Struct. 1998, 27, 59-75.
12. Cox, J., Mann, M., Is proteomics the new genomics? Cell 2007, 130, 395-398.
13. Bockaert, J., Fagni, L., Dumuis, A., Marin, P., GPCR interacting proteins (GIP). Pharmacol. Ther. 2004, 103, 203-221.
14. Bockaert, J., Marin, P., Dumuis, A., Fagni, L., The 'magic tail' of G protein-coupled receptors: An anchorage for functional protein networks. FEBS Lett. 2003, 546, 65-72.
15. Collins, M. O., Grant, S. G., Supramolecular signalling complexes in the nervous system. Subcell. Biochem. 2007, 43, 185-207.
16. Husi, H., Ward, M. A., Choudhary, J. S., Blackstock, W. P., Grant, S. G., Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 2000, 3, 661-669.
17. Au, C. E., Bell, A. W., Gilchrist, A., Hiding, J. et al., Organellar proteomics to create the cell map. Curr. Opin. Cell Biol. 2007, 19, 376-385.
18. Cross, M., Nguyen, T., Bogdanoska, V., Reynolds, E., Hamilton, J. A., A proteomics strategy for the enrichment of receptor-associated complexes. Proteomics 2005, 5, 4754-4763.
19. Josic, D., Clifton, J. G., Mammalian plasma membrane proteomics. Proteomics 2007, 7, 3010-3029.
20. Forler, D., Kocher, T., Rode, M., Gentzel, M. et al., An efficient protein complex purification method for functional proteomics in higher eukaryotes. Nat. Biotechnol. 2003, 21, 89-92.
21. Kocher, T., Superti-Furga, G., Mass spectrometry-based functional proteomics: From molecular machines to protein networks. Nat. Methods 2007, 4, 807-815.
22. Bockaert, J., Dumuis, A., Fagni, L., Marin, P., GPCR-GIP networks: A first step in the discovery of new therapeutic drugs? Curr. Opin. Drug Discov. Dev. 2004, 7, 649-657.
23. Koenig, J. A., Edwardson, J. M., Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol. Sci. 1997, 18, 276-287.
24. Lefkowitz, R. J., Shenoy, S. K., Transduction of receptor signals by beta-arrestins. Science 2005, 308, 512-517.
25. Ferguson, S. S., Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol. Rev. 2001, 53, 1-24.
26. Pierce, K. L., Lefkowitz, R. J., Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat. Rev. Neurosci. 2001, 2, 727-733.
27. Tsao, P., Cao, T., von Zastrow, M., Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol. Sci. 2001, 22, 91-96.
28. Bockaert, J., Roussignol, G., Becamel, C., Gavarini, S. et al., GPCR-interacting proteins (GIPs): Nature and functions. Biochem. Soc. Trans. 2004, 32, 851-855.
29. Milligan, G., G protein-coupled receptors: Oligomerisation and association with accessory proteins. Semin. Cell Dev. Biol. 2004, 15, 261.
30. Changeux, J. P., Edelstein, S. J., Allosteric mechanisms of signal transduction. Science 2005, 308, 1424-1428.
31. Scheuer, T., Catterall, W. A., Control of neuronal excitability by phosphorylation and dephosphorylation of sodium channels. Biochem. Soc. Trans. 2006, 34, 1299-1302.
32. Kim, M., Jiang, L. H., Wilson, H. L., North, R. A., Surprenant, A., Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 2001, 20, 6347-6358.
33. Marin, P., Fagni, L., Torrens, Y., Alcaraz, G. et al., AMPA receptor activation induces association of G-beta protein with the alpha subunit of the sodium channel in neurons. Eur. J. Neurosci. 2001, 14, 1953-1960.
34. Kittler, J. T., Rostaing, P., Schiavo, G., Fritschy, J. M. et al., The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol. Cell. Neurosci. 2001, 18, 13-25.
35. Com, E., Lagadec, C., Page, A., El Yazidi-Belkoura, I. et al., Nerve growth factor receptor TrkA signaling in breast cancer cells involves Ku70 to prevent apoptosis. Mol. Cell. Proteomics 2007, 6, 1842-1854.
36. Huang, H. L., Stasyk, T., Morandell, S., Dieplinger, H. et al., Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 2006, 27, 1641-1650.
37. Wang, Y., Li, R., Du, D., Zhang, C. et al., Proteomic analysis reveals novel molecules involved in insulin signaling pathway. J. Proteome Res. 2006, 5, 846-855.
38. Cartaud, A., Strochlic, L., Guerra, M., Blanchard, B. et al., MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J. Cell Biol. 2004, 165, 505-515.
39. Delcourt, N., Bockaert, J., Marin, P., GPCR-jacking: From a new route in RTK signalling to a new concept in GPCR activation. Trends Pharmacol. Sci. 2007, 28, 602-607.
40. Delcourt, N., Thouvenot, E., Chanrion, B., Galeotti, N. et al., PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons. EMBO J. 2007, 26, 1542-1551.
41. Strochlic, L., Cartaud, A., Cartaud, J., 14-3-3 Gamma, a novel partner of MuSK downregulates synaptic gene transcription at the neuromuscular junction. Med. Sci. (Paris) 2005, 21, 467-469.
42. Strochlic, L., Cartaud, A., Cartaud, J., The synaptic musclespecific kinase (MuSK) complex: New partners, new functions. Bioessays 2005, 27, 1129-1135.
43. Ciruela, F., Burgueno, J., Casado, V., Canals, M. et al., Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal. Chem. 2004, 76, 5354-5363.
44. Fields, S., Song, O., A novel genetic system to detect protein-protein interactions. Nature 1989, 340, 245-246.
45. Tucker, C. L., Gera, J. F., Uetz, P., Towards an understanding of complex protein networks. Trends Cell Biol. 2001, 11, 102-106.
46. Leitner, A., Lindner, W., Chemistry meets proteomics: The use of chemical tagging reactions for MS-based proteomics. Proteomics 2006, 6, 5418-5434.
47. Abul-Husn, N. S., Devi, L. A., Neuroproteomics of the synapse and drug addiction. J. Pharmacol. Exp. Ther. 2006, 318, 461-468.
48. Husi, H., Grant, S. G., Isolation of 2000-kDa complexes of N-methyl-D-aspartate receptor and postsynaptic density 95 from mouse brain. J. Neurochem. 2001, 77, 281-291.
49. Farr, C. D., Gafken, P. R., Norbeck, A. D., Doneanu, C. E. et al., Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents. J. Neurochem. 2004, 91, 438-450.
50. Becamel, C., Gavarini, S., Chanrion, B., Alonso, G. et al., The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J. Biol. Chem. 2004, 279, 20257-20266.
51. Hedman, E., Widen, C., Asadi, A., Dinnetz, I. et al., Proteomic identification of glucocorticoid receptor interacting proteins. Proteomics 2006, 6, 3114-3126.
52. Quinn, A., Harrison, R., Jehanli, A. M., Lunt, G. G., Walsh, S., An ELISA for the detection of anti-acetylcholine receptor antibodies using biotinylated alpha-bungarotoxin. J. Immunol. Methods 1988, 107, 197-203.
53. Rakhilin, S., Drisdel, R. C., Sagher, D., McGehee, D. S. et al., alpha-Bungarotoxin receptors contain alpha7 subunits in two different disulfide-bonded conformations. J. Cell Biol. 1999, 146, 203-218.
54. Rangwala, F., Drisdel, R. C., Rakhilin, S., Ko, E. et al., Neuronal alpha-bungarotoxin receptors differ structurally from other nicotinic acetylcholine receptors. J. Neurosci. 1997, 17, 8201-8212.
55. Free, R. B., Hazelwood, L. A., Cabrera, D. M., Spalding, H. N. et al., D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. J. Biol. Chem. 2007, 282, 21285-21300.
56. Angrand, P. O., Segura, I., Volkel, P., Ghidelli, S. et al., Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling. Mol. Cell. Proteomics 2006, 5, 2211-2227.
57. Brown, A. P., Affleck, V., Fawcett, T., Slabas, A. R., Tandem affinity purification tagging of fatty acid biosynthetic enzymes in Synechocystis sp. PCC 6803 and Arabidopsis thaliana. J. Exp. Bot. 2006, 57, 1563-1571.
58. Collins, M. O., Yu, L., Coba, M. P., Husi, H. et al., Proteomic analysis of in vivo phosphorylated synaptic proteins. J. Biol. Chem. 2005, 280, 5972-5982.
59. Collins, M. O., Yu, L., Husi, H., Blackstock, W. P. et al., Robust enrichment of phosphorylated species in complex mixtures by sequential protein and peptide metal-affinity chromatography and analysis by tandem mass spectrometry. Sci. STKE 2005, 2005, pl6.
60. Feuerstein, I., Morandell, S., Stecher, G., Huck, C. W. et al., Phosphoproteomic analysis using immobilized metal ion affinity chromatography on the basis of cellulose powder. Proteomics 2005, 5, 46-54.
61. Hopf, C., Bantscheff, M., Drewes, G., Pathway proteomics and chemical proteomics team up in drug discovery. Neurodegener. Dis. 2007, 4, 270-280.
62. Moser, K., White, F. M., Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J. Proteome Res. 2006, 5, 98-104.
63. Morandell, S., Stasyk, T., Grosstessner-Hain, K., Roitinger, E. et al., Phosphoproteomics strategies for the functional analysis of signal transduction. Proteomics 2006, 6, 4047-4056.
64. Rush, J., Moritz, A., Lee, K. A., Guo, A. et al., Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23, 94-101.
65. Moron, J. A., Devi, L. A., Use of proteomics for the identification of novel drug targets in brain diseases. J. Neurochem. 2007, 102, 306-315.
66. Zhang, Y., Wolf-Yadlin, A., White, F. M., Quantitative proteomic analysis of phosphotyrosine-mediated cellular signaling networks. Methods Mol. Biol. 2007, 359, 203-212.
67. Pocklington, A. J., Cumiskey, M., Armstrong, J. D., Grant, S. G., The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol. Syst. Biol. 2006, 2, 2006 0023.
68. Whorton, M. R., Bokoch, M. P., Rasmussen, S. G., Huang, B. et al., A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. USA 2007, 104, 7682-7687.
69. Whorton, M. R., Jastrzebska, B., Park, P. S., Fotiadis, D. et al., Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J. Biol. Chem. 2007, 283, 4387-4394.
70. Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J. et al., Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J. Neurosci. 2003, 23, 7820-7829.
71. Gotti, C., Zoli, M., Clementi, F., Brain nicotinic acetylcholine receptors: Native subtypes and their relevance. Trends Pharmacol. Sci. 2006, 27, 482-491.
72. Aggarwal, K., Choe, L. H., Lee, K. H., Shotgun proteomics using the iTRAQ isobaric tags. Brief. Funct. Genomic Proteomic 2006, 5, 112-120.
73. Graumann, J., Hubner, N. C., Kim, J. B., Ko, K. et al., SILAC-labeling and proteome quantitation of mouse embryonic stem cells to a depth of 5111 proteins. Mol. Cell. Proteomics 2008, 7, 672-683.
74. Ishihama, Y., Sato, T., Tabata, T., Miyamoto, N. et al., Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat. Biotechnol. 2005, 23, 617-621.
75. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
76. Schmidt, A., Kellermann, J., Lottspeich, F., A novel strategy for quantitative proteomics using isotope-coded protein labels. Proteomics 2005, 5, 4-15.
77. Dong, M. Q., Venable, J. D., Au, N., Xu, T. et al., Quantitative mass spectrometry identifies insulin signaling targets in C. elegans. Science 2007, 317, 660-663.
78. Jin, J., Meredith, G. E., Chen, L., Zhou, Y. et al., Quantitative proteomic analysis of mitochondrial proteins: Relevance to Lewy body formation and Parkinson's disease. Brain Res. Mol. Brain Res. 2005, 134, 119-138.
79. Missale, C., Nash, S. R., Robinson, S. W., Jaber, M., Caron, M. G., Dopamine receptors: From structure to function. Physiol. Rev. 1998, 78, 189-225.
80. Neve, K. A., Seamans, J. K., Trantham-Davidson, H., Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 2004, 24, 165-205.
81. Aggarwal, K., Lee, K. H., Functional genomics and proteomics as a foundation for systems biology. Brief. Funct. Genomic Proteomic 2003, 2, 175-184.
82. Pellegrini, M., Haynor, D., Johnson, J. M., Protein interaction networks. Expert Rev. Proteomics 2004, 1, 239-249.
83. Strange, K., The end of "naive reductionism": Rise of systems biology or renaissance of physiology? Am. J. Physiol. Cell. Physiol. 2005, 288, C968-C974.
84. Armstrong, J. D., Pocklington, A. J., Cumiskey, M. A., Grant, S. G., Reconstructing protein complexes: From proteomics to systems biology. Proteomics 2006, 6, 4724-4731.
85. Tamminga, C. A., The neurobiology of cognition in schizophrenia. J. Clin. Psychiatry 2006, 67, e11.
86. Miyamoto, S., Duncan, G. E., Marx, C. E., Lieberman, J. A., Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 2005, 10, 79-104.
87. Bai, J., He, F., Novikova, S. I., Undie, A. S. et al., Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins. Biol. Psychiatry 2004, 56, 427-440.
88. Damask, S. P., Bovenkerk, K. A., de la Pena, G., Hoversten, K. M. et al., Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. Brain Res. Mol. Brain Res. 1996, 41, 241-249.
89. Manji, H. K., Drevets, W. C., Charney, D. S., The cellular neurobiology of depression. Nat. Med. 2001, 7, 541-547.
90. Kabbani, N., Levenson, R., Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex. Neuroreport 2006, 17, 299-301.
91. Dahl, J. P., Jepson, C., Levenson, R., Wileyto, E. P. et al., Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics J. 2006, 6, 194-199.
92. Ray, R., Jepson, C., Wileyto, E. P., Dahl, J. P. et al., Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine Tob. Res. 2007, 9, 1237-1241.
93. Dani, D. N., Sainis, J. K., Modularity: A new perspective in biology. Indian J. Biochem. Biophys. 2007, 44, 133-139.